TW200505426A - Analeptic and antidepressant combinations - Google Patents

Analeptic and antidepressant combinations

Info

Publication number
TW200505426A
TW200505426A TW093113418A TW93113418A TW200505426A TW 200505426 A TW200505426 A TW 200505426A TW 093113418 A TW093113418 A TW 093113418A TW 93113418 A TW93113418 A TW 93113418A TW 200505426 A TW200505426 A TW 200505426A
Authority
TW
Taiwan
Prior art keywords
analeptic
antidepressant
combinations
antidepressant combinations
modafinil
Prior art date
Application number
TW093113418A
Other languages
English (en)
Inventor
Rodney J Hughes
Original Assignee
Cephalon Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cephalon Inc filed Critical Cephalon Inc
Publication of TW200505426A publication Critical patent/TW200505426A/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Toxicology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
TW093113418A 2003-05-13 2004-05-13 Analeptic and antidepressant combinations TW200505426A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US46994403P 2003-05-13 2003-05-13
US10/844,135 US20040242698A1 (en) 2003-05-13 2004-05-12 Analeptic and antidepressant combinations

Publications (1)

Publication Number Publication Date
TW200505426A true TW200505426A (en) 2005-02-16

Family

ID=33457162

Family Applications (1)

Application Number Title Priority Date Filing Date
TW093113418A TW200505426A (en) 2003-05-13 2004-05-13 Analeptic and antidepressant combinations

Country Status (14)

Country Link
US (1) US20040242698A1 (zh)
EP (1) EP1633338A1 (zh)
JP (1) JP2007523052A (zh)
KR (1) KR20060023122A (zh)
AR (1) AR047715A1 (zh)
AU (1) AU2004238381A1 (zh)
BR (1) BRPI0411175A (zh)
CA (1) CA2525526A1 (zh)
EA (1) EA200501803A1 (zh)
IS (1) IS8098A (zh)
MX (1) MXPA05012145A (zh)
NO (1) NO20055448L (zh)
TW (1) TW200505426A (zh)
WO (1) WO2004100939A1 (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6992219B2 (en) * 2002-08-09 2006-01-31 Cephalon France Modafinil polymorphic forms
AR045314A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Composiciones farmaceuticas de analepticos y antidepresivos
US20040229941A1 (en) * 2003-05-13 2004-11-18 Cephalon, Inc. Analeptic and antidepressant combinations
AR045423A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Combinaciones de analiticos y antidepresivos
US20040229943A1 (en) * 2003-05-16 2004-11-18 Cephalon Inc Analeptic and drug combinations
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
US20080171750A1 (en) * 2007-01-11 2008-07-17 Braincells, Inc. Modulation Of Neurogenesis With Use of Modafinil
US20100160274A1 (en) * 2007-09-07 2010-06-24 Sharon Sageman 7-KETO DHEA for Psychiatric Use
US20090325999A1 (en) * 2008-06-27 2009-12-31 Jie Du Personalized pharmaceutical kits, packaging and compositions for the treatment of allergic conditions
US9801865B2 (en) * 2008-09-24 2017-10-31 The United States Of America As Represented By The Department Of Veteran Affairs Materials and methods for diagnosis, prevention and/or treatment of stress disorders and conditions associated with abeta peptide aggregation
US11260050B2 (en) 2017-02-16 2022-03-01 United States Government As Represented By The Department Of Veterans Affairs Combination of cotinine plus antioxidant for treatment-resistant depression and correction of astrocytes functional deficit induced by depression and other neuropathological

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2593809B1 (fr) * 1986-01-31 1988-07-22 Lafon Labor Benzhydrylsulfinylacetamide, procede de preparation et utilisation en therapeutique
FR2771004B1 (fr) * 1997-11-19 2000-02-18 Inst Curie Utilisation de derives de benzhydryl sulfinyle pour la fabrication de medicaments ayant un effet eveillant dans des situations de troubles de la vigilance d'origine medicamenteuse
WO2001013921A1 (en) * 1999-08-23 2001-03-01 Ockert David M Triple drug therapy for the treatment of narcotic and alcohol withdrawal symptoms
AR045314A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Composiciones farmaceuticas de analepticos y antidepresivos
US20040229941A1 (en) * 2003-05-13 2004-11-18 Cephalon, Inc. Analeptic and antidepressant combinations
AR045423A1 (es) * 2003-05-13 2005-10-26 Cephalon Inc Combinaciones de analiticos y antidepresivos
US20040229943A1 (en) * 2003-05-16 2004-11-18 Cephalon Inc Analeptic and drug combinations

Also Published As

Publication number Publication date
JP2007523052A (ja) 2007-08-16
EA200501803A1 (ru) 2006-06-30
AU2004238381A1 (en) 2004-11-25
NO20055448D0 (no) 2005-11-17
WO2004100939A1 (en) 2004-11-25
KR20060023122A (ko) 2006-03-13
CA2525526A1 (en) 2004-11-25
WO2004100939B1 (en) 2007-03-01
US20040242698A1 (en) 2004-12-02
AR047715A1 (es) 2006-02-15
BRPI0411175A (pt) 2006-07-18
MXPA05012145A (es) 2006-02-08
NO20055448L (no) 2006-02-01
IS8098A (is) 2005-10-27
EP1633338A1 (en) 2006-03-15

Similar Documents

Publication Publication Date Title
NO20055450L (no) Kombinasjon av et analeptisk modafinili og en antidepressiv forbindelse for behandling av depresjon
SG149063A1 (en) Use of modified cyclosporins for the treatment of hcv disorders
IL244803A0 (en) Human anti-beta7 antibodies and their use
NO20055448L (no) Kombinasjon av et analeptisk modafinil og en antidepressiv forbindelse for behandling av depresjon
MX359668B (es) Derivados de retinal y metodos para su uso en el tratamiento de trastornos visuales.
HK1085140A1 (en) Pharmaceutical compositions and method of using levodopa and carbidopa
MY135829A (en) Analeptic and drug combinations
IL190796A0 (en) Compositions and their uses for gene therapy of bone conditions
TW200716088A (en) Formulations and methods for treating amyloidosis
ZA200701656B (en) Humanized anti-cment antagonists
WO2003103571A3 (en) VACCINES AGAINST FLAVIVIRUSES
EA200601390A1 (ru) Композиции модафинила
EA200802072A1 (ru) Ликопин для лечения нарушения обмена веществ
MX2021012659A (es) Composiciones de seda para el cuidado del cabello.
EE05357B1 (et) Tablett, mis sisaldab v„hemalt kahte eristatavat segmenti, ning selle kasutamine
TW200509895A (en) Analeptic and antidepressant combinations
TW200509894A (en) Analeptic and antidepressant combinations
DE60224667D1 (de) Perylenequinonen zur anwendung als sonosensitizer
CL2004001040A1 (es) Uso de modafinilo para preparar un medicamento util para tratar un desorden depresivo.
AR044360A1 (es) Composiciones farmaceuticas que comprenden un analeptico y otros farmacos
UA96117C2 (ru) Композиция модафинила